---
figid: PMC12154018__ijms-26-05276-g001
figtitle: PI3K/Akt signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12154018
filename: ijms-26-05276-g001.jpg
figlink: /pmc/articles/PMC12154018/figure/F1/
number: F1
caption: 'Overview of the PI3K/Akt signaling pathway. Upon ligand binding, receptor
  tyrosine kinases (e.g., EGFR) activate Class IA PI3K. Ras can act synergistically
  with EGFR to enhance PI3K activation. PI3K phosphorylates PIP2 to generate PIP3,
  which recruits PDK1 and Akt to the plasma membrane. PDK1 and mTORC2 phosphorylate
  Akt at Thr308 and Ser473, respectively, leading to its full activation. Activated
  Akt phosphorylates several downstream targets: GSK3 and FOXO are inhibited upon
  phosphorylation (blunt arrows), promoting biosynthesis, cell survival, growth, and
  proliferation (↑). TSC2 phosphorylation inhibits the TSC1-TSC2 complex, releasing
  its suppression of mTORC1. Activated mTORC1 phosphorylates S6K and 4E-BP1, further
  enhancing cell growth and protein synthesis (↑), while inhibiting autophagy (↓).
  PTEN negatively regulates this pathway by dephosphorylating PIP3 to PIP2. Key alterations
  in this pathway that promote tumorigenesis are highlighted in green and red. 4E-BP1,
  eukaryotic translation initiation factor 4E-binding protein; Akt, protein kinase
  B; EGFR, epidermal growth factor receptor; eIF4E, eukaryotic translation initiation
  factor 4E; FOXO, forkhead box O; GSK3, glycogen synthase 3; mTOR, mammalian target
  of rapamycin; mTORC1, mammalian target of rapamycin complex 1; mTORC2, mammalian
  target of rapamycin complex 2; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase;
  PDK1, phosphatidylinositol-dependent kinase 1; PIP2, phosphatidylinositol-4,5-bisphosphate;
  PIP3, phosphatidylinositol-3,4,5-triphosphate; PTEN, phosphatase and tensin homologue;
  S6K, ribosomal protein S6 kinase; TSC1, tuberous sclerosis complex 1; TSC2, tuberous
  sclerosis complex 2'
papertitle: 'PIK3CA Mutations: Are They a Relevant Target in Adult Diffuse Gliomas?'
reftext: Ana Tomás, et al. Int J Mol Sci. 2025 Jun;26(11).
year: '2025'
doi: 10.3390/ijms26115276
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: glioma | glioblastoma | PIK3CA mutations | PI3K/Akt pathway | targeted therapy
  | PI3K inhibitors | alpelisib | cancer biomarkers
automl_pathway: 0.9442493
figid_alias: PMC12154018__F1
figtype: Figure
redirect_from: /figures/PMC12154018__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12154018__ijms-26-05276-g001.html
  '@type': Dataset
  description: 'Overview of the PI3K/Akt signaling pathway. Upon ligand binding, receptor
    tyrosine kinases (e.g., EGFR) activate Class IA PI3K. Ras can act synergistically
    with EGFR to enhance PI3K activation. PI3K phosphorylates PIP2 to generate PIP3,
    which recruits PDK1 and Akt to the plasma membrane. PDK1 and mTORC2 phosphorylate
    Akt at Thr308 and Ser473, respectively, leading to its full activation. Activated
    Akt phosphorylates several downstream targets: GSK3 and FOXO are inhibited upon
    phosphorylation (blunt arrows), promoting biosynthesis, cell survival, growth,
    and proliferation (↑). TSC2 phosphorylation inhibits the TSC1-TSC2 complex, releasing
    its suppression of mTORC1. Activated mTORC1 phosphorylates S6K and 4E-BP1, further
    enhancing cell growth and protein synthesis (↑), while inhibiting autophagy (↓).
    PTEN negatively regulates this pathway by dephosphorylating PIP3 to PIP2. Key
    alterations in this pathway that promote tumorigenesis are highlighted in green
    and red. 4E-BP1, eukaryotic translation initiation factor 4E-binding protein;
    Akt, protein kinase B; EGFR, epidermal growth factor receptor; eIF4E, eukaryotic
    translation initiation factor 4E; FOXO, forkhead box O; GSK3, glycogen synthase
    3; mTOR, mammalian target of rapamycin; mTORC1, mammalian target of rapamycin
    complex 1; mTORC2, mammalian target of rapamycin complex 2; PI3K, phosphatidylinositol-4,5-bisphosphate
    3-kinase; PDK1, phosphatidylinositol-dependent kinase 1; PIP2, phosphatidylinositol-4,5-bisphosphate;
    PIP3, phosphatidylinositol-3,4,5-triphosphate; PTEN, phosphatase and tensin homologue;
    S6K, ribosomal protein S6 kinase; TSC1, tuberous sclerosis complex 1; TSC2, tuberous
    sclerosis complex 2'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - CUX1
  - SART3
  - PTEN
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - TSC2
  - TSC1
  - CCL26
  - AKT1S1
  - MTOR
  - DEPTOR
  - RPTOR
  - EIF4EBP1
  - RPS6KB1
  - PRR5
  - MLST8
  - MAPKAP1
  - RICTOR
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - Ras
  - RAPTOR
---
